Cassone, Giulia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.400
AS - Asia 5.721
EU - Europa 4.302
SA - Sud America 910
AF - Africa 163
OC - Oceania 85
Continente sconosciuto - Info sul continente non disponibili 5
Totale 20.586
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.145
SG - Singapore 1.800
CN - Cina 1.482
IT - Italia 1.134
GB - Regno Unito 954
HK - Hong Kong 649
BR - Brasile 648
VN - Vietnam 606
SE - Svezia 467
DE - Germania 318
FI - Finlandia 309
FR - Francia 236
RU - Federazione Russa 222
KR - Corea 199
JP - Giappone 159
TR - Turchia 154
IN - India 149
ID - Indonesia 145
CA - Canada 120
UA - Ucraina 117
IE - Irlanda 109
AR - Argentina 96
MX - Messico 93
AU - Australia 75
NL - Olanda 73
BG - Bulgaria 72
PK - Pakistan 56
BD - Bangladesh 55
IQ - Iraq 52
TN - Tunisia 51
PL - Polonia 48
LT - Lituania 45
ZA - Sudafrica 40
CL - Cile 34
EC - Ecuador 34
MY - Malesia 32
ES - Italia 30
CO - Colombia 29
AT - Austria 26
PE - Perù 24
PH - Filippine 21
AE - Emirati Arabi Uniti 20
SA - Arabia Saudita 20
VE - Venezuela 20
HU - Ungheria 18
PT - Portogallo 18
JO - Giordania 17
EG - Egitto 15
KE - Kenya 14
MA - Marocco 14
NP - Nepal 14
BE - Belgio 13
BZ - Belize 13
DK - Danimarca 12
DZ - Algeria 12
IR - Iran 12
RS - Serbia 11
CH - Svizzera 10
NZ - Nuova Zelanda 10
RO - Romania 10
PY - Paraguay 9
TW - Taiwan 9
UZ - Uzbekistan 9
TH - Thailandia 8
BO - Bolivia 7
DO - Repubblica Dominicana 7
LB - Libano 7
LV - Lettonia 7
CZ - Repubblica Ceca 6
OM - Oman 6
UY - Uruguay 6
AZ - Azerbaigian 5
BY - Bielorussia 5
CY - Cipro 5
GR - Grecia 5
HR - Croazia 5
IL - Israele 5
EU - Europa 4
HN - Honduras 4
LU - Lussemburgo 4
MD - Moldavia 4
MU - Mauritius 4
EE - Estonia 3
GT - Guatemala 3
GY - Guiana 3
JM - Giamaica 3
KG - Kirghizistan 3
KH - Cambogia 3
KW - Kuwait 3
KZ - Kazakistan 3
NI - Nicaragua 3
PA - Panama 3
PS - Palestinian Territory 3
SN - Senegal 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
ET - Etiopia 2
GH - Ghana 2
Totale 20.562
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.257
Singapore 1.147
Ashburn 943
Fairfield 853
Hong Kong 626
Chandler 507
San Jose 469
Hefei 464
Southend 451
Woodbridge 341
Houston 293
Seattle 276
Nyköping 264
London 263
Wilmington 263
Helsinki 261
Cambridge 240
Beijing 230
Ann Arbor 215
The Dalles 214
Ho Chi Minh City 181
Council Bluffs 179
Seoul 169
Los Angeles 167
New York 144
Jacksonville 142
Hanoi 136
Modena 122
Dallas 112
Dearborn 110
Milan 110
Chicago 108
Jakarta 105
San Diego 97
Shanghai 88
Moscow 79
Dublin 76
Lauterbourg 71
Sofia 70
Princeton 68
Redwood City 64
São Paulo 64
Buffalo 63
Tokyo 60
Orem 57
Rome 57
Munich 56
Perth 47
Salt Lake City 47
Bologna 44
Frankfurt am Main 42
Izmir 41
Bremen 39
Eugene 36
Da Nang 35
Mexico City 34
Manchester 33
Columbus 31
Elk Grove Village 29
Montreal 29
Nuremberg 29
Kent 27
Warsaw 27
Chennai 26
Toronto 26
Falls Church 25
Haiphong 25
Brooklyn 24
San Francisco 24
Ankara 22
Mumbai 22
Atlanta 21
Bari 21
Boardman 21
Istanbul 21
Redondo Beach 21
Rio de Janeiro 21
Santiago 21
Baghdad 20
Amsterdam 19
Paris 19
Turku 19
Boston 18
Dong Ket 18
Johannesburg 18
Guangzhou 17
Quito 16
Stockholm 16
Brasília 15
Buenos Aires 15
Catania 15
Amman 14
Lappeenranta 14
Ottawa 14
Tampa 14
Tunis 14
Belize City 13
Bogotá 13
Denver 13
Las Vegas 13
Totale 13.590
Salva come PNG Salva come JPEG
Nome #
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 1.332
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 412
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 398
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 339
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 337
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 330
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 326
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 319
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 318
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 312
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 303
Caratteristiche cliniche e nuovi orizzonti diagnostico-terapeutici delle vasculiti dei grandi vasi e della interstiziopatia polmonare secondaria ad artrite reumatoide. 298
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 298
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 296
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 277
COST ANALYSIS RELATED TO SUBCUTANEOUS IMMUNOGLOBULINS IN PATIENTS WITH INFLAMMATORY MYOPATHIES AND IMMUNE-MEDIATED CHRONIC NEUROPATHIES. RESULTS OF AN OPEN LABEL STUDY 273
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 272
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 269
High-dose glucocorticoids pulse-Therapy for beta-coronaviridae pneumonia: A systematic literature review and case-series of coronavirus disease-2019 268
The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients 265
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review 254
[18F]fluorodeoxyglucose positron emission tomography imaging in a case of relapsing polychondritis 253
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study 251
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 246
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 244
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 242
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia 240
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study 238
Classification of pulmonary sounds through deep learning for the diagnosis of interstitial lung diseases secondary to connective tissue diseases 231
Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma 231
Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients 227
Factors Predicting Early Failure of Etanercept in Rheumatoid Arthritis: An Analysis From the Gruppo Italiano di Studio sulla Early Arthritis (Italian Group for the Study of Early Arthritis) Registry 223
Erratum: Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature (Journal of Thoracic Disease (2019) 11 (1621-1628) DOI: 10.21037/jtd.2019.03.28) 219
Nailfold videocapillaroscopy in antisynthetase syndrome 218
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease 218
Severe alopecia complicating systemic sclerosis 214
Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review 213
PAP-TEST FEATURES IN A COHORT OF SYSTEMIC SCLEROSIS PATIENTS 210
Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series 203
CHARACTERIZATION OF ANTI-MPO POSITIVE INTERSTITIAL LUNG DISEASE. CLINICAL-SEROLOGIC AND RADIOLOGIC FEATURES AND SURVIVAL 202
FRI0613 THERAPEUTIC STRATEGIES AND SURVIVAL IN PATIENTS WITH INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES 201
Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium 197
Rituximab therapy for primary central nervous system vasculitis: A 6 patient experience and review of the literature 195
Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming? 195
VECTOR: An algorithm for the detection of COVID-19 pneumonia from velcro-like lung sounds 193
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 191
Human Dental Pulp Stem Cells Modulate Cytokine Production in vitro by Peripheral Blood Mononuclear Cells From Coronavirus Disease 2019 Patients 186
Usefulness of digital velcro crackles detection in identification of interstitial lung disease in patients with connective tissue diseases 183
Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows 181
The rediscovery of hydroxychloroquine in allergic diseases in the covid-19 era 178
Treatment with Rituximab in Systemic Sclerosis Patients: Our Experience in a Pilot Clinical Trial 177
Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy 173
Diagnosis, Clinical Features and Management of Interstitial Lung Diseases in Rheumatic Disorders: Still a Long Journey 173
Axial Spondyloarthritis: Reshape the Future—From the “2022 GISEA International Symposium” 172
Granulomatosis with polyangiitis presenting as a renal mass successfully treated with rituximab 171
EVALUATION OF INTERNAL CONSISTENCY, FEASIBILITY, AND RELIABILITY OF THE ITALIAN VERSION OF ANCA-ASSOCIATED VASCULITIS PATIENT-REPORTED OUTCOME (AAV-PRO_ITA) QUESTIONNAIRE: PRELIMINARY RESULTS FROM A MULTICENTER STUDY ON A LARGE COHORT OF ITALIAN PATIENTS 170
NAILFOLD CAPILLAROSCOPIC ALTERATIONS IN DERMATOMYOSITIS AND POLYMYOSITIS 170
Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis 166
Fibrosing interstitial lung disease in primary Sjogren syndrome 163
Interstitial pneumonia with autoimmune features: Why rheumatologist–pulmonologist collaboration is essential 162
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: results from the extension of the TOPAZIO study 159
EFFICACY OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS TREATMENTS ACCORDING TO THE TYPE OF MANIFESTATIONS BASED ON ANALYSIS OF 636 PATIENTS 157
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: A population-based study 155
Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) 154
117. PREDICTION OF LONG-TERM EVOLUTIONARY PROFILES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG– STRAUSS) BASED ON BASELINE AND FOLLOW-UP CHARACTERISTICS 153
354. EFFICACY OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS TREATMENTS ACCORDING TO THE TYPE OF MANIFESTATIONS BASED ON ANALYSIS OF 636 PATIENTS 153
Effects in soluble immune checkpoints induced by Tocilizumab monotherapy after ultra-short-term glucocorticoids in large vessel – giant cell arteritis patients 152
Pathogenesis and treatment of idiopathic and rheumatoid arthritis-related interstitial pneumonia. The possible lesson from COVID-19 pneumonia 148
JANUS KINASES INHIBITORS IN CLINICAL PRACTICE IN ITALY. RESULTS FROM A SINGLE CENTER EXPERIENCE 148
Tocilizumab or glucocorticoids treatment for patients with SARS-CoV-2 pneumonia: An observational study 147
Lung involvement in systemic sclerosis: role of high resolution computed tomography and its relationship with other pulmonary and clinico-serological features. 145
Predictive factors of clinical outcomes in patients with COVID-19 treated with tocilizumab: A monocentric retrospective analysis 144
CLINICAL OUTCOMES OF TREATMENT WITH GOLIMUMAB IN SEROPOSITIVE AND SERONEGATIVE RHEUMATOID ARTHRITIS PATIENTS IN REAL-LIFE SETTINGS. DATA FROM ITALIAN REGISTER GISEA 143
Pneumopathie interstitielle fibrosante dans le syndrome de Gougerot-Sjögren primitif 142
Interstitial lung disease and anti-myeloperoxidase antibodies: not a simple association 138
Erratum to: Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement (Clinical Rheumatology, (2017), 36, 6, (1261-1268), 10.1007/s10067-017-3601-1) 137
Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study 136
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 134
Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for Rheumatology 133
Reactive Granulomatous Dermatitis during Anti-TNF Therapy: A Case Report and Review of the Literature 128
Rheumatoid arthritis related interstitial lung disease 127
Therapeutic Strategies and Survival in Patients with Interstitial Pneumonia with Autoimmune Features 126
SAT0470 Pap-Test Features in a Cohort of Systemic Sclerosis Patients 126
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire 124
Trattamento con Tocilizumab in monoterapia dopo trattamento con glucocorticoidi per breve periodo in pazienti con arterite a cellule giganti con coinvolgimento dei grandi vasi: effetti sui checkpoint immunitari solubili 122
Granuloma annulare as a possible new adverse effect of topiramate 121
POS1053 PREVALENCE OF FIBROSING PROGRESSIVE INTERSTITIAL LUNG DISEASE IN RHEUMATOID ARTHRITIS PATIENTS 118
FRI0212 THE ROLE OF AGE ON THE CLINICAL PRESENTATION AND RELAPSE RATES IN A LARGE COHORT OF 720 PATIENTS WITH GIANT CELL ARTERITIS 118
Pulmonary Progressive Fibrosis in Rheumatoid Arthritis and Primary Sjogren Syndrome: Similarities and Differences 115
Prevalence of Progressive Fibrosing Interstitial Lung Disease in Patients with Primary Sjogren Syndrome 115
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: the role of imaging in a prospective observational study 113
From Bench to Bedside in Rheumatoid Arthritis from the “2022 GISEA International Symposium” 107
NAILFOLD CAPILLAROSCOPY IN ANTISYNTHETASE SYNDROME (NASCAR): RESULTS OF A MULTICENTER, INTERNATIONAL STUDY OF THE AMERICAN AND EUROPEAN NETWORK OF ANTISYNTHETASE SYNDROME (AENEAS) 103
Rheumatoid Arthritis from Easy to Complex Disease: From the "2022 GISEA International Symposium" 96
Radiomics to predict the mortality of patients with rheumatoid arthritis-associated interstitial lung disease: A proof-of-concept study 92
PREDICTION OF LONG-TERM EVOLUTIONARY PROFILES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG-STRAUSS) BASED ON BASELINE AND FOLLOW-UP CHARACTERISTICS 90
EARLY DISCONTINUATION OF FIRST LINE BIOLOGICAL TREATMENT WITH ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM THE ITALIAN GISEA REGISTRY 89
HARNESSING THE POWER OF RADIOMICS TO PREDICT SURVIVAL IN PATIENTS WITH RA-ILD 89
Rheumatoid arthritis extra-articular lung disease: new insights on pathogenesis and experimental drugs 88
Reply to the comment on: Hypereosinophilic bronchiolitis in ANCA-associated vasculitis: where does it stand? by Bilgin et al 85
Totale 20.486
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.088
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.088
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021282 0 0 0 0 0 0 0 0 0 0 143 139
2021/20221.747 144 106 111 99 91 137 81 91 209 173 321 184
2022/20231.874 211 178 145 138 211 215 87 207 230 47 115 90
2023/20241.590 68 89 75 232 219 125 129 254 47 54 123 175
2024/20254.678 143 69 108 319 961 737 396 205 489 174 451 626
2025/20267.112 533 368 640 920 975 599 1.041 390 882 682 82 0
Totale 20.825